NM_201384.3:c.6507G>A

Variant names:

• chr8-143923422-C-T
• rs199866902
• NM_201384.3:c.6507G>A
• PLEC p.Lys2169Lys

GermlineCancer (beta)

Variant summary

Our verdict is Benign.

-9 Benign

-7

-6

-1

0

+5

+6

+9

+10

BenignB

Likely BenignLB

UncertainVUS

Likely PathogenicLP

PathogenicP

The variant received -9 classification points (ACMG Germline Pathogenicity v2019). BP4_StrongBP6_StrongBP7

The NM_201384.3(PLEC):c.6507G>A (p.Lys2169Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000273 (AC=439) in the gnomAD database across 1,610,544 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.00465. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.0015 (0 hom., cov: 33)
  • Exomes 𝑓: 0.00015 (1 hom.)
• Consequence: PLEC NM_201384.3 synonymous
• Clinical Significance: Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6
• Conservation: PhyloP100: 0.384
• Publications: 2 publications found

Genes affected

PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]

PLEC Gene-Disease associations (from GenCC):

• PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder

  Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
• epidermolysis bullosa simplex

  Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: G2P, LiferaOmics
• epidermolysis bullosa simplex 5A, Ogna type

  Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Genomics England PanelApp
• autosomal recessive limb-girdle muscular dystrophy type 2Q

  Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
• congenital myasthenic syndrome

  Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
• epidermolysis bullosa simplex 5B, with muscular dystrophy

  Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
• epidermolysis bullosa simplex 5C, with pyloric atresia

  Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
• progressive familial intrahepatic cholestasis

  Inheritance: AR Classification: MODERATE Submitted by: PanelApp Australia
• aplasia cutis congenita

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• cholestasis

  Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -9 points.

Apply	Criterion Code & Title / Strength	Strength	Rationale / Clinical Context
	BP4Computational evidence suggests no impact		Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
	BP6Reputable source reports benign		ClinVar 2-star benign — strong (BP6); ClinVar germline classification: Benign/Likely Benign, 2 star(s).
	BP7Synonymous variant, no splicing impact		Synonymous variant at non-conserved position with no predicted splicing impact (BP7); Synonymous at non-conserved position, no splicing concern — benign (BP7).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_201384.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.	Gene / Transcript	Tags	HGVSc / HGVSp	Effect	Exon rank	Protein / UniProt
	PLEC NM_201384.3	MANE Select	c.6507G>A p.Lys2169Lys	synonymous	Exon 31 of 32	Prot: NP_958786.1 UniProt:
	PLEC NM_201378.4	MANE Plus Clinical	c.6465G>A p.Lys2155Lys	synonymous	Exon 31 of 32	Prot: NP_958780.1 UniProt:
	PLEC NM_201380.4		c.6918G>A p.Lys2306Lys	synonymous	Exon 31 of 32	Prot: NP_958782.1 UniProt:

PLEC NM_201384.3

MANE Select

HGVSc / HGVSpc.6507G>Ap.Lys2169Lys

Exon rankExon 31 of 32

synonymous

Prot: NP_958786.1UniProt: Q15149-4

PLEC NM_201378.4

MANE Plus Clinical

HGVSc / HGVSpc.6465G>Ap.Lys2155Lys

Exon rankExon 31 of 32

synonymous

Prot: NP_958780.1UniProt: Q15149-9

PLEC NM_201380.4

HGVSc / HGVSpc.6918G>Ap.Lys2306Lys

Exon rankExon 31 of 32

synonymous

Prot: NP_958782.1UniProt: Q15149-1

Ensembl Transcripts

Sel.	Gene / Transcript	Tags	HGVSc / HGVSp	Effect	Exon rank	Protein / UniProt
	PLEC ENST00000345136.8	TSL:1MANE Select	c.6507G>A p.Lys2169Lys	synonymous	Exon 31 of 32	Prot: ENSP00000344848.3 UniProt:
	PLEC ENST00000356346.7	TSL:1MANE Plus Clinical	c.6465G>A p.Lys2155Lys	synonymous	Exon 31 of 32	Prot: ENSP00000348702.3 UniProt:
	PLEC ENST00000322810.8	TSL:1	c.6918G>A p.Lys2306Lys	synonymous	Exon 31 of 32	Prot: ENSP00000323856.4 UniProt:

PLEC ENST00000345136.8

TSL:1MANE Select

HGVSc / HGVSpc.6507G>Ap.Lys2169Lys

Exon rankExon 31 of 32

synonymous

Prot: ENSP00000344848.3UniProt: Q15149-4

PLEC ENST00000356346.7

TSL:1MANE Plus Clinical

HGVSc / HGVSpc.6465G>Ap.Lys2155Lys

Exon rankExon 31 of 32

synonymous

Prot: ENSP00000348702.3UniProt: Q15149-9

PLEC ENST00000322810.8

TSL:1

HGVSc / HGVSpc.6918G>Ap.Lys2306Lys

Exon rankExon 31 of 32

synonymous

Prot: ENSP00000323856.4UniProt: Q15149-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)

Rare (AF ≤ 0.0001 / Hom ≤ 1)

Source / population	AF	AC	Hom	AN	Coverage
Global population databases 6 sources Large-scale international reference populations
GnomAD3 genomes	AF: 0.00149	AC:227	Hom:0	AN:152218	Cov:33
GnomAD2 exomes	AF: 0.000379	AC:90	Hom:	AN:237564	Cov:
GnomAD4 exome	AF: 0.000145	AC:212	Hom:1	AN:1458208	Cov:71
GnomAD4 genome	AF: 0.00149	AC:227	Hom:0	AN:152336	Cov:33
TOPMed (Bravo)	AF: 0.00171	AC:452	Hom:1	AN:264690	Cov:
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)	AF: 0.00172	AC:78	Hom:1	AN:45304	Cov:
Local & regional cohorts 3 sources Population-specific and national genomic databases
ESP6500 (Exome Variant Server)	AF: 0.00110	AC:14	Hom:	AN:12704	Cov:
GenomeAsia100K	AF: 0.000577	AC:2	Hom:	AN:3478	Cov:
Qatari Genome	AF: 0.00180	AC:3	Hom:	AN:1706	Cov:

Showing 9 sources

Case/control cohorts

Cohort	Cases			Controls
	AF	AC	AN	AF	AC	AN
Epi25(Epilepsy)	0.000405	17	41958	0.000419	28	66888
SCHEMA(Schizophrenia)	0.000854	82	96016	0.000810	118	145600

Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions

Significance: Benign/Likely benign

Revision: criteria provided, multiple submitters, no conflicts

Pathogenic	VUS	Benign	Condition
-	-	3	not provided (3)
-	-	2	not specified (2)
-	-	1	Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy (1)

Computational Scores

Algorithm	Calibrated pred.	Score	Prediction
AlphaGenome AVI	Benign	2.6
BayesDel_noAF	Benign	-0.61
CADD	Benign	0.91
DANN	Benign	0.91
GPN-Star LLR	N/A	-1.2
GPN-Star score	N/A	1.2
PhyloP100	Benign	0.38

Showing 7 of 7 scores

Splicing Scores

Algorithm	Calibrated pred.	Score	Prediction
Pangolin (max)	Benign	0.0
SpliceAI score (max)	Benign	0.0	Details are displayed if max score is > 0.2

Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Other links and lift over

dbSNP: rs199866902;

hg19: chr8-144997590;

ACMG debug oncogenicity

ACGS debug oncogenicity

ACMG debug germline

Submit to ClinVar